The Supreme Court of India has ignited a critical debate: Should families of individuals who allegedly died due to COVID-19 vaccines receive compensation? This legal and ethical dilemma has drawn national attention, forcing the government to rethink its stance on vaccine-related deaths.
On February 25, the Supreme Court asked the central government if a policy could be framed to compensate families of individuals who died due to adverse effects from COVID-19 vaccines. The government’s response was cautious. It clarified that while COVID-19 itself was classified as a disaster under the Disaster Management Act, vaccine-related deaths were not included in the same category. This means that while financial aid was provided to families of those who died from COVID-19, no such mechanism exists for those who allegedly lost their lives due to vaccine complications.
According to Additional Solicitor General (ASG) Aishwarya Bhati, the COVID-19 vaccination program followed global medical protocols, with mechanisms in place to monitor and respond to adverse effects. She argued that vaccine-related deaths cannot automatically be equated with pandemic-related fatalities. However, the Supreme Court challenged this logic. It pointed out that the vaccination drive was a direct response to the pandemic, making it difficult to separate the two.
The Supreme Court was clear in its observation that denying compensation for vaccine-related deaths while acknowledging COVID-19 fatalities as a disaster is contradictory. The bench emphasized that the entire vaccination initiative was part of the pandemic response. Therefore, dismissing vaccine-related deaths as unrelated to COVID-19 itself seemed unjustified.
The court asked the central government to reconsider its position and explore the possibility of framing a compensation policy. It gave the government three weeks to come up with a response, scheduling the next hearing for March 18.
This is not the first time a court has asked the government to address vaccine-related fatalities. In 2022, a woman who lost her husband due to alleged vaccine side effects petitioned the Kerala High Court for compensation. At that time, the Kerala HC found that there was no clear policy addressing vaccine-related deaths. It directed the National Disaster Management Authority (NDMA) to create guidelines for identifying and compensating affected families.
However, the central government challenged the Kerala High Court’s order in the Supreme Court, which put the directive on hold until 2023. The Supreme Court is now re-examining the issue, raising hopes that a concrete decision may finally be made.
One of the key arguments made by the petitioner’s counsel is the inconsistency in the government’s compensation policy. More than 14 lakh people who died due to COVID-19 were compensated. In contrast, there is no relief mechanism for those who lost their lives due to adverse vaccine reactions, despite official mechanisms acknowledging such risks.
While rare, adverse effects following immunization (AEFI) have been documented worldwide. The World Health Organization (WHO) and other global health agencies have acknowledged that, in very few cases, vaccines can trigger severe reactions leading to fatalities. Despite this, the Indian government remains hesitant to recognize vaccine-related deaths for compensation.
The debate raises a larger ethical question: Should the government take responsibility for medical interventions promoted during a public health emergency? COVID-19 vaccines were fast-tracked under emergency use authorizations, and citizens were urged and even mandated in many cases to take them.
If vaccines were a public necessity and were made compulsory for travel, jobs, and access to public spaces, should those who suffered adverse effects be left without recourse? Critics argue that ignoring vaccine-related deaths could set a dangerous precedent, discouraging public trust in future vaccination programs.
On the other hand, the government’s concern is that compensating vaccine-related deaths could trigger widespread fear and legal battles. If a blanket compensation policy is introduced, it might open the floodgates for claims, straining public funds and creating further controversies over causation.
The government now has three weeks to decide whether it will frame a policy for compensating vaccine-related deaths or continue to resist the demand. It has two choices:
1. Accept the Kerala High Court’s directive and create a policy to assess and compensate vaccine-related deaths.
2. Maintain its current position that only COVID-19 fatalities (not vaccine-related deaths) qualify for compensation.
If the government chooses the latter, the Supreme Court could push back, potentially ruling in favour of compensation. This could lead to a landmark decision shaping India’s approach to public health responsibilities and legal accountability.
India is not the only country struggling with this issue. Several nations have set up compensation programs for vaccine-related injuries.
United States: The National Vaccine Injury Compensation Program (VICP) provides financial relief to individuals who suffer severe vaccine-related complications.
United Kingdom: The UK’s Vaccine Damage Payment Scheme offers a lump sum of £120,000 to individuals who experience significant disability or death due to vaccines.
Canada: The Canadian government launched a similar program in 2020 to support individuals harmed by COVID-19 vaccines.
These international examples highlight the fact that compensating vaccine injuries is not unprecedented. If India follows suit, it could restore public confidence in government-backed medical interventions.
At the heart of this debate is the balance between public health interests and individual justice. The COVID-19 vaccination drive was one of the largest in history, credited with saving millions of lives. However, for the small percentage of people who suffered fatal complications, the absence of a compensation mechanism feels like a betrayal.
The Supreme Court’s intervention could be a game-changer, forcing the government to acknowledge and address the unintended consequences of its public health policies. Whether India frames a new policy or not, this case will set a precedent for how the country handles vaccine safety concerns in the future.
With the next hearing set for March 18, all eyes are on the central government’s response. Will it take responsibility, or will affected families be left fighting a lonely legal battle? The coming weeks will determine the course of justice for those who lost loved ones in the fight against COVID-19.